2026-01-22 - Analysis Report
**Company Overview:** Oracle is a multinational technology company that provides enterprise software, cloud infrastructure, and professional services.

**Return Comparison:**

* Cumulative Return of Review Stock (ORCL): 64.69%
* Cumulative Return of Comparison Stock (VOO, S&P 500): 91.55%
* Degree of Divergence: -27.86% (difference in cumulative return on the last day of the data)

The review stock (ORCL) has underperformed the comparison stock (VOO) by 27.86%. The divergence is currently at -12.30% (relative divergence of 16.50%), which is lower than the minimum of -39.60.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 0.0% | 15.4% | -5.0% | 1.0 | 129.7B |
| 2017-2019  | 11.0% | 15.4% | -7.0% | 1.0 | 152.2B |
| 2018-2020  | -3.0% | 27.3% | -24.0% | 0.9 | 185.9B |
| 2019-2021  | 9.0% | 27.3% | -35.0% | 0.9 | 250.6B |
| 2020-2022  | 4.0% | 29.9% | 6.0% | 0.9 | 234.8B |
| 2021-2023  | 16.0% | 29.9% | 15.0% | 0.9 | 302.9B |
| 2022-2024  | 66.0% | 22.1% | 47.0% | 1.0 | 478.8B |
| 2023-2025  | 60.0% | 44.8% | -2.0% | 1.4 | 560.0B |

The CAGR (Compound Annual Growth Rate) for the review period is variable, with some periods showing significant growth and others showing decline. The MDD (Maximum Drawdown) ranges from 15.4% to 44.8%, indicating significant market fluctuation. The Alpha (excess return) ranges from -35.0% to 47.0%, and the Beta (systematic risk) ranges from 0.9 to 1.4.

**5-day/20-day/60-day Moving Average:**

* Close: $173.88
* Last-market: {'price': 173.88, 'previousClose': 179.92, 'change': -3.36}
* 5-day SMA: $185.67
* 20-day SMA: $193.75
* 60-day SMA: $213.31

The stock price has been declining, with a recent drop of $3.36. The 5-day SMA and 20-day SMA are below the current price, indicating a short-term downtrend. The 60-day SMA is also below the current price, indicating a longer-term downtrend.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence:**

* Market Risk Indicator (MRI): 0.80
* RSI: 30.49
* PPO: -0.50
* Hybrid Signal: Buy
* Risk Level: Medium
* Recent (20 days) relative divergence change: -3.80 (worsening)
* 7-day Rank change: 15 (+): rank up
* 7-day Dynamic Expected Return change: -1.20 (-): worsening
* Expected Return (%): 31.80%

The stock has a moderate risk indicator (MRI) of 0.80, with a relative strength index (RSI) of 30.49, indicating oversold conditions. The PPO index is -0.50, indicating a bearish signal. The hybrid signal is "Buy", but the risk level is medium. The recent relative divergence change is worsening, indicating a decreasing trend. The 7-day rank change is increasing, but the expected return change is decreasing.

**Recent News & Significant Events:**

* [2026-01-21] Oracle Stock: How To Find & Own America's Greatest Opportunities - Investor's Business Daily (news.google.com)
* [2026-01-21] Oracle Stock To $126? - Forbes (news.google.com)
* [2026-01-21] Oracle (ORCL) Is Down 11.1% After AI Debt Disclosure Lawsuit Raises Questions About Funding Model - Yahoo Finance (news.google.com)
* [2026-01-19] Oracle to pay dividends on January 23; Here’s how much 100 ORCL shares will earn - Finbold (news.google.com)
* [2026-01-18] Microsoft vs. Oracle: Which OpenAI Partner Is a Better Buy for 2026? - The Motley Fool (news.google.com)
* [2026-01-19] Oracle stock price: ORCL set for Tuesday return as AI debt lawsuit, credit risk stay in focus - TechStock² (news.google.com)

**Analyst Opinions:**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.77 (~Buy)
- Opinions: 38
- Target Price (avg/high/low): 291.61 / 400.00 / 175.14

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-12-11 | 2.14 | 16.06 B$ |
| 2025-09-10 | 1.04 | 14.93 B$ |
| 2025-03-11 | 1.05 | 14.13 B$ |
| 2024-12-10 | 1.13 | 14.06 B$ |
| 2025-12-11 | 1.13 | 14.06 B$ |

The earnings per share (EPS) have been variable, ranging from 1.04 to 2.14. The revenue has been increasing over time, with a recent peak of $16.06 billion.

**Financial Information:**

### Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-11-30 | $16.06B | 66.53% |
| 2025-08-31 | $14.93B | 67.28% |
| 2025-05-31 | $15.90B | 70.19% |
| 2025-02-28 | $14.13B | 70.31% |
| 2024-11-30 | $14.06B | 70.94% |

The revenue has been consistently high, with a peak of $16.06 billion in the most recent quarter. The profit margin has also been consistently high, ranging from 66.53% to 70.94%.

### Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-11-30 | $29.95B | 20.48% |
| 2025-08-31 | $24.15B | 12.12% |
| 2025-05-31 | $20.45B | 16.76% |
| 2025-02-28 | $16.73B | 17.55% |
| 2024-11-30 | $13.75B | 22.92% |

The equity has been consistently increasing over time, with a peak of $29.95 billion in the most recent quarter. The return on equity (ROE) has also been consistently high, ranging from 12.12% to 22.92%.

**Comprehensive Analysis:**

* The review stock (ORCL) has underperformed the comparison stock (VOO) by 27.86% in cumulative return.
* The CAGR (Compound Annual Growth Rate) for the review period is variable, with some periods showing significant growth and others showing decline.
* The RSI (Relative Strength Index) is oversold at 30.49, and the PPO index is -0.50, indicating a bearish signal.
* The recent relative divergence change is worsening, indicating a decreasing trend.
* The analyst consensus is "Buy" with a target price range of $175.14 to $400.00.
* The recent earnings per share (EPS) have been variable, ranging from 1.04 to 2.14.
* The revenue has been consistently high, with a peak of $16.06 billion in the most recent quarter.
* The profit margin has also been consistently high, ranging from 66.53% to 70.94%.
* The equity has been consistently increasing over time, with a peak of $29.95 billion in the most recent quarter.
* The return on equity (ROE) has also been consistently high, ranging from 12.12% to 22.92%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.